Answers are grounded in this paper and cite their sources.
Psoriasis is the most common autoimmune skin condition affecting around 2-3% of world population which in severe cases found associated with comorbidities like arthritis and heart condition, etc.To measure the severity of the illness based on induration, erythema, and scaling, psoriasis area severity index PASI score is used.Present study was performed to analyse PASI score by conducting antipsoriatic activity of cholecalciferol containing nanoemulsion CONE with UV exposure in imiquimod induced psoriatic wistar model.The study was conducted in four groups; namely, Group I control, Group II test, Group III normal and Group IV imiquimod treated.During extensive study of 44 days, including induction of psoriasis under standard conditions as per CPCSEA guidelines, followed by its treatment with fixed doses of 40000 IU of CONE and UV at 395 nm topically starting from 14th day on groups.Out of which, healing rate was high in Group II CONE with UV treatment and showed synergic effect in wistar model and PASI score was found to be low as compared to other groups.Thus, it can be concluded that antipsoriatic activity of CONE had positive effect on imiquimod induced psoriatic wistar model.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: